Akorn Pharmaceuticals

Akorn Investor Relations

SEC Filings

Filing date Form Description Filing Group View
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

Other
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

Other
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

Other
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

Other
25

Notification filed by National Securities Exchange to report the removal from listing and registration on a national securities exchange

Other
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
3

Initial filing by director officer or owner of more than ten percent.

3,4,5